38
Hospital Corporation of China Limited
3869.HK · HKSE
$3.40 +0.00% (+$0.00)
Market Cap ¥619.9M
P/E Ratio -
Div. Yield -
ROE 27.23%
Bulios Fair Price
$4.01
17.9% upside
Current Price
$3.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 3869.HK is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
100 /100
Cheap P/FCF 3.15x
P/B 1.22x
EV/EBITDA 2.48x
Growth
86 /100
Growing FCF growth 35.01%
Book val. growth 44.34%
Rev. growth 40.64%
Profitability
44 /100
Moderate FCF margin 7.73%
Op. margin 12.19%
Gross margin 19.02%
Quality
73 /100
Excellent Asset turnover 1.00x
ROA 4.13%
ROIC 10.74%
Debt
54 /100
Moderate Net debt/EBITDA 0.99x
Int. coverage 2.50x
Debt/Equity 2.01x
Stability
13 /100
Unstable Profitable years 0
EPS volatility 279.29%
Beta -0.31x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 3869.HK
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Xiaofeng Lang
Employees
1,835
Headquarters
Beijing